admissions for lowcr-respiratorv illncss and gastroeiiteritis dtiritig the first five ycars. Lancct 1982;i: 1227-9. 10 Welsh JK, May JI. Anti-infective protperties of breast milk. 7 Objective-To study the persistence of hypoglycaemic symptoms, changes in blood glucose concentrations, and the relation between reported symptoms and measured blood glucose values in functional hypoglycaemia.
Design-Re-evaluation of symptoms in patients admitted consecutively with suspected hypoglycaemia followed by a case-control study.
Setting-The Steno Memorial Hospital in Gentofte, Denmark, which specialises in the diagnosis and treatment of and research on endocrine disorders, including hypoglycaemia.
Patients-21 Subjects admitted consecutively with hypoglycaemic symptoms that were relieved by eating in whom insulinoma and other organic disorders presenting with hypoglycaemia had been ruled out. Twelve of these subjects with persistent symptoms entered the case-control study, as did a matched control group.
Interventions-Four days of monitoring blood glucose concentrations at home, six daily samples being taken in fixed relation to meals by the finger prick method. Extra samples were taken when symptoms occurred.
Main outcome measures-Blood glucose concentration, glycated haemoglobin concentration, and within subject variation in measured values.
Results-After one to three years of observation 19 of the 21 subjects still had symptoms. usual symptoms during the four days of the study: one patient had three episodes, one two episodes, and four one episode. Blood glucose concentrations ranged from 3 7 mmol/l to 7 5 mmol/l during these episodes. Apart from hunger, which was reported by all six subjects, the pattern of symptoms was comparable with that in the whole group. The mean changes in blood glucose concentration (figure) and mean blood glucose values at each time point were not significantly different from those in the control group, both for all patients and for the six patients reporting symptoms. No blood glucose values Design-Prospective randomised allocation to one of two prophylactic antibiotic regimens in a parallel group trial. Group sequential analyses of each 250 patients were performed.
Setting-14 District general and teaching hospitals.
Patients-1018 Adults having colorectal operations were randomised, of whom 943 were evaluated. Demographic features, conditions requiring surgery, and operative procedures were similar in the two groups. Most patients had surgery for carcinoma of the colon or rectum.
Interventions-Group 1 received cefotaxime 1 g intravenously plus metronidazole 500 mg intravenously preoperatively. Group 2 received cefuroxime 1-5 g intravenously plus metronidazole 500 mg intravenously preoperatively, followed by cefuroxime 750 mg intravenously plus metronidazole 500 mg intravenously eight hours and 16 hours postoperatively.
Main outcome measures-Development of surgical wound infection (as evidenced by the presence of pus), death, or discharge from hospital.
Results-Wound condition was scored on a five point scale on alternate days until discharge or for up to 20 days postoperatively. Wound infection rates were: group 1, 32/453 (7.1%; 95% confidence interval 4-7% to 9.4%); group 2, 33/454 (7.3%; 95% confidence interval 4-9% to 9.6%). Death rates (group 1: 26/470 (5-5%); group 2: 31/471 (6.6%)), the incidence of postoperative complications, the median duration of hospital stay (12 days), and antibiotic tolerance were all similar in the two groups. Pooled data from groups 1 and 2 showed that wound infections were more frequent when minor faecal contamination had occurred at operation and when the duration of operation exceeded 90 minutes (>90 min 11-2% of cases; <90 min 4-8%) and were associated with an extended hospital stay.
Conclusions-A single preoperative dose of cefotaxime plus metronidazole is as efficacious as a three dose regimen ofcefuroxime plus metronidazole in preventing wound infection after colorectal surgery and has practical advantages in eliminating the need for postoperative antibiotics.
Introduction
The use of antibiotics for prophylaxis against wound infection is well established in patients having operations on the gastrointestinal tract, particularly the large bowel, where the risk of infection from faecal micro-organisms is high.' 2 Despite acceptance of antibiotic prophylaxis in principle there is wide variation in the composition and duration of the antibiotic regimens employed.34 The ideal prophylactic regimen for large bowel surgery would exemplify activity against both aerobic and anaerobic bacteria with a consequent low incidence of wound infection, safety from unwanted drug effects, convenience of delivery, and low cost. A single preoperative dose of prophylactic antibiotics shown to be ofequal efficacy to a commonly used multiple dose regimen would satisfy these criteria. Though 
